Vanessa Vela
Child & Adolescent Psychiatry · San Antonio, TXNPI 1598813248
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 42.2% of the total. Reporting peaked in 2024 at $924 and has fallen 62.0% since, to $351 in 2025.
Across 111 payments — averaging $26.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Supernus Pharmaceuticals, Inc.$417
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$236
- Otsuka America Pharmaceutical, Inc.$234
- Teva Pharmaceuticals USA, Inc.$139
- Vanda Pharmaceuticals Inc.$125
- plus $573 from 11 others
What the payments were for
- Food & beverage$2,981100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 53 | $1,256 |
| Supernus Pharmaceuticals, Inc. | 11 | $417 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $236 |
| Otsuka America Pharmaceutical, Inc. | 8 | $234 |
| Teva Pharmaceuticals USA, Inc. | 2 | $139 |
| Vanda Pharmaceuticals Inc. | 5 | $125 |
| Noven Therapeutics, LLC | 6 | $115 |
| Angiodynamics, Inc. | 1 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $82 |
| Axsome Therapeutics, Inc. | 3 | $64 |
| Tris Pharma Inc | 3 | $60 |
| Ironshore Pharmaceuticals Inc. | 2 | $48 |
| Johnson & Johnson | 2 | $36 |
| Arbor Pharmaceuticals, Inc. | 2 | $26 |
| Shire North American Group Inc | 1 | $18 |
| Bausch Health US, LLC | 1 | $16 |
| Adlon Therapeutics L.p. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,981 in reported general payments places this provider in the 85th percentile of 301 child & adolescent psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 65 | $2,904 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 30 | $2,002 |
| Aripiprazole | 25 | $1,550 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 33 | $961 |
| Oxcarbazepine | 16 | $922 |
| Lamotrigine | 32 | $745 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 25 | $504 |
| Escitalopram Oxalate | 15 | $487 |
| Lorazepam | 30 | $477 |
| Trazodone Hcl | 25 | $459 |
| Buspirone Hcl | 11 | $446 |
| Clonazepam | 37 | $422 |
| Paroxetine Hcl | 11 | $386 |
| Alprazolam | 65 | $368 |
| Diazepam | 26 | $316 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in San Antonio
- Steven PliszkaSan Antonio$59K
- Mary Garcia HolguinSan Antonio$24K
- Maria DominguezSan Antonio$7K
- Amber MansoorSan Antonio$6K
- Andrew MartinSan Antonio$6K
- Thomas DemoorSan Antonio$5K
- Marguerite HoganSan Antonio$3K
- Grace Salinas GarciaSan Antonio$2K
- Hector SamaniegoSan Antonio$2K
- Alain KaticBellaire$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.